Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$34.3K Hold
163
0.02% 86
2026
Q1
$36K Hold
163
0.03% 76
2025
Q4
$41.3K Buy
+163
New +$40.9K 0.03% 74

Other funds holding STE

NorthAvenue LLC's STE Position: Q2 2026 in Review

NorthAvenue LLC held its Steris (STE) position steady in Q2 2026 at 163 shares worth $34.3K. The position accounts for 0.02% of the portfolio, ranked #86.

NorthAvenue LLC first reported a position in STE in Q4 2025 and has held it in 3 quarters since. The position peaked at $41.3K in Q4 2025. 251 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • NorthAvenue LLC held 163 shares of Steris worth $34.3K as of Q2 2026.
  • NorthAvenue LLC left its Steris share count unchanged in Q2 2026.
  • Steris made up 0.02% of NorthAvenue LLC's portfolio in Q2 2026, its #86 holding.
  • NorthAvenue LLC first reported a position in Steris in Q4 2025 and has held it in 3 quarters since.
  • NorthAvenue LLC's Steris position peaked at $41.3K in Q4 2025.
  • 251 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on NorthAvenue LLC's 13F filing for Q2 2026, filed 21 Jul 2026.